Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Receivables (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Change in Receivables data on record, last reported at $102000.0 in Q4 2025.

  • For Q4 2025, Change in Receivables rose 104.82% year-over-year to $102000.0; the TTM value through Dec 2025 reached -$912000.0, up 74.27%, while the annual FY2025 figure was -$912000.0, 74.27% up from the prior year.
  • Change in Receivables reached $102000.0 in Q4 2025 per SGHT's latest filing, up from $98000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $4.3 million in Q2 2024 and bottomed at -$7.2 million in Q3 2024.
  • Average Change in Receivables over 5 years is $270850.0, with a median of $495500.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: soared 19800.0% in 2022, then plummeted 786.26% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$13000.0 in 2021, then skyrocketed by 19800.0% to $2.6 million in 2022, then tumbled by 211.21% to -$2.8 million in 2023, then grew by 25.63% to -$2.1 million in 2024, then surged by 104.82% to $102000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $102000.0 in Q4 2025, $98000.0 in Q3 2025, and $215000.0 in Q2 2025.